<DOC>
	<DOC>NCT00158873</DOC>
	<brief_summary>The study will evaluate the pharmaco-economic consequences of the use of a remifentanil based regimen compared with a conventional sedative based regimen in terms of duration of mechanical ventilation, length of stay in ICU, difference in extubation time and use of concomitant sedative agents.</brief_summary>
	<brief_title>Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<criteria>ICU patients with an expected duration of mechanical ventilation for 2 to 3 days and requiring analgesia and sedation. Exclusion criteria: ICU patients resuscitated in the previous 24 hours, neurotrauma or expecting major surgery, not likely to survive of with limit care status.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>ICU mechanical ventilation analgesia sedation</keyword>
</DOC>